Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.
Vaccines (Basel)
; 11(1)2022 Dec 27.
Article
in En
| MEDLINE
| ID: mdl-36679903
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Vaccines (Basel)
Year:
2022
Document type:
Article
Affiliation country: